The structural gene of the Proteus mirabilis glutathione transferase GSTB1-1 (gstB) has been isolated from genomic DNA. A nucleotide sequence determination of gstB predicted a translational product of 203 amino acid residues, perfectly matching the sequence of the previously purified protein [Mignogna, Allocati, Aceto, Piccolomini, Di Ilio, Barra and Martini (1993) Eur. J. Biochem. 211, 421-425]. The P. mirabilis GST sequence revealed 56 % identity with the Escherichia coli GST at DNA level and 54 % amino acid identity. Similarity has been revealed also with the translation products of the recently cloned gene bphH from Haemophilus influenzae (28 % identity) and ORF3 of Burkholderia cepacia (27 % identity). Putative promoter sequences with high similarity to the E. coli σ(! consensus promoter
INTRODUCTION
Glutathione transferases (GSTs ; EC 2.5.1.18) are a family of multifunctional dimeric proteins that catalyse the conjugation of the sulphur atom of glutathione to a large variety of electrophilic compounds of both endobiotic and xenobiotic origin [1] [2] [3] [4] . GSTs are also involved in the intracellular binding and transport of hydrophobic compounds, participate in the synthesis of prostaglandins and leukotrienes, and might play a key role in the elimination of organic hydroperoxides [1] [2] [3] . Most cytosolic GSTs so far characterized have been classified into at least five classes : Alpha, Mu, Pi, Theta and Sigma [5] [6] [7] . GSTs have also been isolated from micro-organisms [8] [9] [10] [11] [12] [13] [14] , but little is known about their biological functions, structures and regulation. In our laboratory we have previously purified a GST from Proteus mirabilis (GSTB1-1) that did not react with antisera against mammalian GST [9] . The complete amino acid sequence of GSTB1-1 has been recently resolved, indicating low sequence similarity to mammalian and plant GST [15] . However, despite their low sequence similarity, limited proteolysis studies [16] have indicated a common three-dimensional organization to mammalian and bacterial GSTs. By immunolabelling techniques we found that the GSTB1-1 content in the periplasmic space is much higher than in the cytoplasm [17] . By assuming that GSTB1-1 has a role in detoxification, its predominantly periplasmic location could represent a boundary against the toxic effect of xenobiotics, including antibiotics [18] . In P. mirabilis, as in other bacteria, GSTB1-1 is present in very low amounts, about 0.06 % of the total protein extract [9, 18] , setting a limit to the study of the physico-chemical properties of this enzyme. Thus the availability of a system for high-yield heterologous expression is Abbreviations used : CDNB, 1-chloro-2,4-dinitrobenzene ; GSH, glutathione ; GST, glutathione transferase ; IPTG, isopropyl-β-D-thiogalactopyranoside ; LB, Luria-Bertani ; MIC, minimum inhibitory concentration, ORF, open reading frame.
§ To whom correspondence should be addressed. The nucleotide sequence reported will appear in DDBJ, EMBL and GenBank Nucleotide Sequence Databases under the accession number U38482.
and to promoters of P. mirabilis cat and glnA genes preceded the ATG of the gstB open reading frame (ORF). gstB was brought under control of the tac promoter and overexpressed in E. coli by induction with isopropyl-β--thiogalactopyranoside and growth at 37 mC. The physicochemical and catalytic properties of overexpressed protein were indistinguishable from those of the enzyme purified from P. mirabilis extract. Unlike the GST belonging to Mu and Theta classes, GSTB1-1 was unable to metabolize dichloromethane. The study of the interaction of cloned GSTB1-1 with a number of antibiotics indicates that this enzyme actively participates in the binding of tetracyclines and rifamycin.
needed. Such a system is also necessary to clarify the role of bacterial GST in the detoxification of endobiotics as well as xenobiotics. Of particular interest is the proposed role of bacterial GST in the binding of antibiotics [18] .
Here we describe the molecular cloning and overexpression of GSTB1-1 in Escherichia coli to yield high levels of the active enzyme. In addition, to understand better the relationship of bacterial GST with antimicrobial agents, the interactions of cloned GSTB1-1 with several classes of antibiotics have also been investigated.
MATERIALS AND METHODS

Bacterial strains, plasmids and culture conditions
To clone and express GSTB1-1 the Escherichia coli XL1-Blue strain was used [19] . It was grown on Luria-Bertani (LB) medium [20] , supplemented with tetracycline (12.5 µg\ml) and ampicillin (50 µg\ml) when appropriate. pBluescript II KSj (Stratagene, La Jolla, CA, U.S.A.) and pBTac1 (Boehringer Mannheim, Germany) were used as cloning and expression vectors respectively.
Chemicals
Isopropyl-β--thiogalactopyranoside (IPTG) and 5-bromo-4-chloro-3-indolyl-β--galactopyranoside, as well as all antibiotics used in the present work, were purchased from Sigma-Aldrich (Milan, Italy). All other reagents used were of the highest grade commercially available.
DNA techniques
Genomic DNA isolation, transformation and other cloning procedures were done by standard techniques [20] . Preparative amounts of plasmid DNA were obtained by using Qiagen columns (Qiagen Inc., Chatsworth, CA, U.S.A.). Transformations and other cloning procedures were done by standard techniques [20] . Restriction enzymes were obtained from Boehringer and digestions were performed as recommended by the manufacturers. DNA amplification was performed by PCR by using GeneAmp PCR Reagent Kit with AmpliTaq DNA Polymerase or UlTma DNA Polymerase (Perkin Elmer Cetus, Norwalk, CT, U.S.A.). Southern hybridization was performed with Hybond-N membrane filters (Amersham, Bucks, U.K.), the non-radioactive DIG DNA labelling kit and the DIG Luminescent Detection kit (Boehringer) in accordance with the suppliers' instructions. DNA sequences were determined by the dideoxy-chain termination method [21] 
Sequence analysis
Nucleic acid sequences were analysed by using the MacVector program, version 4.1.4 (IBI, New Haven, CT, U.S.A.).
Enzyme purification
To induce the gstB gene transcription, IPTG was added to a final concentration of 1 mM when E. coli strains, grown at 37 mC in LB medium supplemented with tetracycline and ampicillin, reached an approximate A &&! of 0.4, and the incubation was prolonged for a further 4 h. The cells were collected by centrifugation, washed twice and resuspended in 10 mM potassium phosphate buffer, pH 7.0, containing 1 mM EDTA (buffer A), and disrupted by cold sonication (five bursts of 3 min each at 300 W) with a Labsonic 1510 (Braun) sonicator. The particulate material was removed by centrifugation at 105 000 g for 1 h at 4 mC and the supernatant loaded on a glutathione-Sepharose affinity column [22] that had been pre-equilibrated with buffer A. The column was washed with buffer A supplemented with 50 mM KCl. The enzyme was eluted with 50 mM Tris\HCl buffer, pH 9.6, supplemented with 5 mM glutathione (GSH). The fractions containing GST activity were pooled, concentrated and dialysed by ultrafiltration and used for further studies.
Analytical procedures
SDS\PAGE in discontinuous slab gel was performed by the method of Laemmli [23] . The SDS concentration was 0.1 % and the spacer and the separating gels contained 3 % and 12.5 % (w\v) acrylamide respectively. Western blots were made essentially by the protocol described by Towbin et al. [24] with a slight modification as described previously [18] . Isoelectric focusing was performed in accordance with the manufacturer's instructions on a 5 % (w\v) polyacrylamide horizontal slab gel with 2.2 % (w\v) Ampholine, pH 3.5-9.5 (Ampholine PAG plate ; Pharmacia). HPLC analysis was performed by the method described by Ostlund-Farrants et al. [25] with a Vydak 201 TP5 column (Crompack, Middelburg, The Netherlands) equilibrated with 30 % (v\v) acetonitrile in 0.1 % (v\v) trifluoroacetic acid. The column was developed at 1 ml\min by a 60 min linear gradient from 30 % to 60 % acetonitrile in 0.1 % trifluoracetic acid. Protein contents were determined by the method of Bradford [26] with γ-globulin as standard.
Enzyme assay
GST activity towards 1-chloro-2,4-dinitrobenzene (CDNB), 1,2-dichloro-4-nitrobenzene, ethacrynic acid, p-nitrobenzyl chloride, 1,2-epoxy-3-(p-nitrophenoxy)propane, trans-4-phenyl-3-buten-2-one, ∆&-androstene 3,17-dione, p-nitrophenyl acetate and bromosulphthalein was assayed at 30 mC by the methods of Habig and Jakoby [27] . The selenium-independent glutathione peroxidase activity of GST was measured with cumene hydroperoxide as previously reported [28] . GST activity towards 4-nitroquinoline 1-oxide was measured as reported by Stanley and Benson [29] . Dichloromethane dehalogenase activity was determined as described by Staub and Leisinger [30] .
Inhibition studies
The effects of antibiotics as inhibitors were measured by using 1 mM CDNB and 1 mM GSH in 10 mM potassium phosphate buffer, pH 6.5, plus 1 mM EDTA. Stock solutions of antibiotics were freshly prepared immediately before use by the method of Anhalt and Washington [31] . The enzyme was preincubated with antibiotics for at least 1 min before the addition of substrates. The inhibition of GSTB1-1 was determined by using at least ten different concentrations of each antibiotic. The IC &! value represents the concentration of drug causing 50 % inhibition of activity.
For the enzyme kinetic determinations either CDNB or GSH was held constant at 1 and 5 mM respectively, while the concentration of the other substrate varied (from 0.1 to 5 mM for GSH and from 0.1 to 1.6 mM for CDNB). To study the nature of antibiotic inhibition the kinetic parameters of GSTB1-1 were also determined in the presence of the drugs. In all cases the data fitted well to the equation for a rectangular hyperbola. Fitting was carried out with the computer program ENZFITTER based on an iterative Gauss-Newton procedure [32] .
Growth curve
A single colony of E. coli XL1Blue (pGPT1) was inoculated into LB medium and grown overnight in a water bath shaker. LB medium (150 ml) containing 3 ml of overnight culture and 1 mM IPTG was incubated at 37 mC in a water bath shaker, monitoring the absorbance at 600 nm. When an absorbance of 0.250 was reached, the cells were exposed to one-eighth, one-quarter and one-half of the minimum inhibitory concentration (MIC) of antibiotic. A sample without IPTG was used as control. MIC values of 50, 100 and 3.2 µg\ml, found for rifamycin, tetracycline and minocycline respectively, were determined by a standard broth microdilution technique [33] .
RESULTS AND DISCUSSION
Cloning and nucleotide sequence of the P.mirabilis gstB gene
On the basis of the amino acid sequence of GSTB1-1 [15] two degenerate oligonucleotides were designed : a 25-mer corresponding to the N-terminal amino acid residues 1-6, 5h-GCGAATTC ATG AA(A\G) (C\T)TI TA(C\T) TA(C\T) AC-3h (primer 1), and a 29-mer corresponding to the C-terminal residues 198-203 with an additional stop codon, 5h-GCGAATTC TTA (C\T)TC (C\T)TT IAT IA(A\G) ICC (C\T)TC-3h (primer 2). Both primers had a 5h recognizing site for the restriction enzyme EcoRI (underlined) and a CG tail to facilitate the cloning procedure. PCR was performed with the two oligonucleotides to amplify a fragment from P. mirabilis genomic DNA corresponding to the entire gstB coding region. A PCR product of approx. 600 bp was obtained. It was eluted from agarose gel, digested with the restriction enzyme EcoRI and cloned in the unique EcoRI site of the E. coli vector pBluescript II KSj. The analysis of the nucleotide sequence of four recombinant plasmids revealed that they carried 609 bp fragments coding for 203 amino acids, agreeing with the size of the previously sequenced protein, but none of them coded a protein perfectly matching GSTB1-1. Conservative and non-conservative nucleotide substitutions were found in two regions corresponding to the annealing sites of the primers, as a foreseeable consequence of their degenerate nature, and also in other regions (at a rate of about 0.25 %), presumably due to the use of an error-prone Taq polymerase in the PCR reaction. These latter results confirmed the inadequacy of Taq polymerases in obtaining a correct amplification product in polymerization reactions of few hundred nucleotides, as in our case.
To obtain the cloning of the correct sequence, the EcoRI fragment corresponding to the gstB gene was labelled and used to probe, by Southern hybridization, the P. mirabilis genomic DNA digested with different restriction enzymes. The HindIII digestion gave a unique hybridization band corresponding to a 2.1 kb fragment. Pooled fragments of a HindIII digestion of P. mirabilis genomic DNA between 1.8 and 2.4 kb in size were cloned in pBluescript II KSj. Screening of 300 recombinant E. coli XL1Blue clones by colony hybridization with the gstB probe led to the identification of two positive clones. The foreign fragments of the two recombinant plasmids were sequenced in their terminal regions, yielding identical results. The nucleotide sequence of the 2123 bp HindIII fragment in one of the two plasmids, referred to as pGPB1, is shown in Figure 1 . Three putative coding regions with a size greater than 300 nt were identified : the first, ORF1, at position 1-299 is the 3h segment of a truncated open reading frame (ORF), 75 % identical with the 3h region of the E. coli en M gene [34] ; the second, at position 521-1129, is gstB ; the third, ORF2, is transcribed in the opposite direction from nt 1738 to nt 1214, its entire putative translation product being 41 % identical with the C-terminal region of a hypothetical unidentified protein (GenBank accession number U11243-1) of Haemophilus influenzae [35] .
The gstB starts with an ATG codon (nt 521), ends with a TAA codon (nt 1130) and is preceded by a potential ribosome binding site (Figure 1) . The GjC content of gstB is 39.7 mol %, in agreement with the GjC content of Proteus [36] . Its predicted translational product of 203 amino acids matched the sequence of the purified protein exactly [15] .
The search for similarities with promoting regions from enteric bacteria revealed : a hexamer at position 294 identical with the putative k35 sequence of the P. mirabilis cat gene [37] ; two sequences similar in five out of six bases to the k10 putative region of the P. ulgaris glnA gene [38] at positions 309 and 314 ; and two hexamers, one at position 411 and the other at position 438, similar in five out of six bases to the k35 and k10 regions respectively of the E. coli σ(! consensus promoter [39] . Three regions with a thorough dyad symmetry are present downstream of the gstB TAA stop codon and could be involved in transcription termination. A structure with a similar function is downstream of the TAA of the putative ORF1. Two imperfect complementary inverted sequences were found internal to the gstB coding region, at positions 798-838 and 1084-1117.
The P. mirabilis gstB ORF product was 56 % identical with the E. coli gst product [13] , the only prokaryotic gene encoding a product with a canonical GST activity. The region between the en M-similar ORF1 and gstB did not show similarity to the region downstream of the E. coli en M, nor with the region upstream of the E. coli gst gene, consistent with the different map positions of en M and gst genes in E. coli [13, 34] . However, the ORF2 C-terminal fragment (residues 137-174) of P. mirabilis was 63 % identical with the translation of the 3h region downstream of the E. coli gst gene, running in the opposite direction, and nucleotides previously identified as a putative truncated ORF, indicating a similar organization of this region in both bacteria.
The similarity of GSTB1-1 to eukaryotic GSTs has been discussed previously [13, 15, 40, 41] . The similarity of GSTB1-1 to bacterial GST and GST-like proteins has been reported by some authors [13, 15, 40, 41] . During this work a further sequence analysis revealed a 28 % identity of GSTB1-1 with the putative bphH gene from H. influenzae [35] and 27 % identity with the ORF3 of Burkholderia cepacia involved in the degradation of 2,4,5-trichlorophenoxyacetic acid [42] . The identity in both cases increased to 35 % if the N-terminal region up to position 80 was considered, as already observed by Mignogna et al. [15] .
Expression and characterization of GSTB1-1 in E. coli
The E. coli XL1Blue (pGPB1) clone was tested for the production of recombinant GST. Immunoblot analysis revealed that the protein was expressed but quantification, after the affinity chromatography step, indicated a low production of enzyme. However, the recombinant GST was, by analytical procedures, identical with GSTB1-1 isolated from P. mirabilis [9] . With the aim of obtaining an E. coli clone overproducing the recombinant enzyme, gstB was amplified by PCR from pGPB1 plasmid by using primer 1 and primer 2 and the proofreading DNA polymerase UlTma. The PCR products were cloned after EcoRI digestion in the EcoRI site of pBluescript and sequenced. Out of three amplified products, one showed a nucleotide sequence perfectly matching the amino acid sequence despite conservative nucleotide substitutions at positions 7 (T C), 15 (C T), 600 (A G) and 603 (A C) owing to primer degeneration. gstB was cloned in the EcoRI site of pBTac1 vector under the tac promoter, obtaining the pGPT1 plasmid (Figure 2) . Induced E. coli XL1Blue cells bearing pGPT1 overexpressed a protein with an apparent subunit molecular mass of 22.5 kDa (Figure 3) , which cross-reacted with the antisera raised against native GSTB1-1. The yield of cloned GSTB1-1 was about 45 mg per litre of culture, which is about 240-fold higher than the yield from P. mirabilis lysate [9] . The HPLC elution profiles of both native and cloned GSTB1-1 were essentially identical, showing a single peak eluting respectively at 37.84p0.03 min and 37.95p0.025 (meanpS.D.) min. A single band centred at pH 6.1 was obtained when both native and cloned GSTB1-1 were submitted to isoelectrofocusing analysis (Figure 4) . Similar to the result obtained with native GSTB1-1, the cloned enzyme has a narrow range of substrate specificities [9] . In fact, as can be seen in Table 1 , the recombined GSTB1-1, in addition to its capacity to reduce cumene hydroperoxide, is able to conjugate GSH only to CDNB and ethacrynic acid.
Collectively, these results clearly indicate that the recombinant GSTB1-1 is structurally, kinetically and immunologically indistinguishable from native GSTB1-1.
It has been demonstrated that different species of methylotrophic bacteria contain dichloromethane dehalogenase, an enzyme that is able to catalyse the degradation of dichloromethane to formaldehyde, using GSH as co-substrate [43, 44] . This enzyme, although structurally different from the mammalian GST, is now considered to be a member of the Theta class of the GST family [43] . Furthermore Meyer et al. [7] and Blocki et al. [43] have demonstrated that Theta class GSTs, and to a smaller extent Mu class GSTs, have the capacity to transform dichloromethane into formaldehyde. When GSTB1-1 was tested for its capacity to metabolize dichloromethane no significant activity was found.
This finding seems to support the idea that mammalian Theta class GST is more closely related to dichloromethane dehalogenase than to bacterial GST. 
Interaction with antibiotics
A possible binding role for bacterial GST in antibiotic resistance has been suggested previously [18] . The interaction of a range of antibiotics with GSTB1-1 was investigated. In the first series of experiments GSTB1-1 was tested for sensitivity in itro to the action of several classes of antibiotics. In Table 2 respectively. Nalidixic acid, norfloxacin, oxolinic acid, ampicillin, amoxacillin, piperacillin, erythromycin, troleandromycin, tobramycin and kanamycin up to a concentration of 5 mM were ineffective in inhibiting GSTB1-1 activity. To understand better the nature of the interaction, GSTB1-1 kinetic parameters in the presence and in the absence of the classes representing the antibiotics cefotaxime, tetracycline, rifamycin, chloramphenicol and nitrofurantoin were determined (Table 3 ). All drugs tested produced a significant decrease (to approx. onehalf to one-third) in the k cat values of GSTB1-1 for both substrates. These results indicate that GSTB1-1 binds the antibiotics listed in Table 3 at a site or sites remote from the catalytic site (GSH site) or the CDNB binding site (H site). Furthermore the fact that the drugs, in addition to decreasing the k cat values, also caused a significant decrease in the K m value for CDNB
Figure 5 Effect of rifamycin, minocycline and tetracycline on the growth rate of cells overexpressing GSTB1-1
Symbols : , 1/2iMIC plus IPTG ; , 1/2iMIC without IPTG ; #, 1/4iMIC plus IPTG ; $, 1/4iMIC without IPTG ; >, 1/8iMIC plus IPTG ; >, 1/8iMIC without IPTG. MIC values are : 50 µg/ml for rifamycin, 3.2 µg/ml for minocycline and 100 µg/ml for tetracycline.
suggests that the binding of antibiotics induces a conformational change in the protein, affecting the CDNB binding site.
In view of the binding capacity of the bacterial GST towards antibiotics, the growth rate of GSTB1-1-overexpressed cells, in the presence of different concentrations of rifamycin and tetracyclines, was measured and compared with cells not overexpressed for GSTB1-1. As can be seen in Figure 5 , rifamycin, but not tetracyclines, differentially affected the growth rate of cells overexpressed and not overexpressed for GSTB1-1. In fact in the presence of 6.25-25 µg\ml rifamycin the cells overexpressing GSTB1-1 continued to grow, whereas the growth of cells not overexpressing GSTB1-1 was substantially inhibited.
In conclusion, these results clearly indicate that GSTB1-1 is able to sequester antibiotics with avidity. This suggests that GSTB1-1 might be involved in resistance to several classes of antibiotic, particularly rifamycin. Alternatively, in view of the role of GST in protecting the cells from toxic insult, it is possible that tetracyclines and rifamycin, as well as other antibiotics, might impair the detoxication of other xenobiotics or endobiotics that are metabolized through the mercapturic acid pathway. Studies based on X-ray crystallography and site-directed mutagenesis are under way to improve our understanding of the relationship between GSTB1-1 and antibiotics.
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